Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Butterbur - Nutraceuticals World
Research

Butterbur

Indication: Intermittent allergic rhinitis (hay fever)

Source: Phytotherapy Res, June 2005; 19(6):530-537.

Research: A prospective, randomized, double-blind, parallel group comparison study of butterbur extract (Ze 339; 8 mg total petasine; one tablet thrice-daily), fexofenadine (Telfast 180, one tablet once-daily) and placebo was conducted in 330 patients. Protocol and analysis were arranged according to the latest guidelines on new treatments for allergic rhinitis. The primary efficacy variable was a change in symptoms from baseline to endpoint during daytime. The secondary efficacy variables were: (a) as per primary variable (evening/ night); (b) physician’s global assessment; (c) responder rates. Safety was also closely monitored.

Results: Although both active treatments were individually significantly superior to placebo in improving symptoms of hay fever, there were no differences between the two active treatments in treating hay fever. As a result, the researchers concluded that despite being an herbal drug, butterbur, specifically Ze 339, has now been subject to a series of well controlled trials and should be considered as an alternative treatment for hay fever.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters